Shield Therapeutics: Clinical Trials

9 trials sponsored by Shield Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 5 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 12Completed 2

Follow Shield Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Ferric Maltol, Ferrous sulfate - Anemia, Iron-deficiency
Phase 3CompletedShield Therapeutics652021-11-032025-11-10
Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers
Ferric maltol capsule, Ferric maltol suspension - Anemia, Iron Deficiency
Phase 1CompletedShield Therapeutics322020-09-282025-08-24
EXPLorative Data Collection for Patient chAracterIzation, treatmeNt Pathways and Outcomes of IRON Preparations
Iron Supplement - Iron-deficiency
CompletedGWT-TUD GmbH512018-01-162019-07-02
Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )
Anemia, Iron Deficiency, Inflammatory Bowel Diseases
CompletedShield Therapeutics592017-08-142020-10-23
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
Ferric Maltol - Iron Deficiency, Anaemia in Children, Iron-Deficiency
Phase 1CompletedShield Therapeutics372017-03-142021-10-06
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Ferric maltol, Placebo - Renal Insufficiency, Chronic, Iron-Deficiency Anemia
Phase 3CompletedShield Therapeutics1672016-12-012020-11-02
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Ferric Maltol, Ferric Carboxy Maltose - Anemia, Iron-Deficiency, Inflammatory Bowel Disease
Phase 3CompletedShield Therapeutics2502016-01-012020-11-02
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
ST10, Placebo oral capsule - Iron Deficiency Anaemia, Inflammatory Bowel Disease
Phase 3CompletedShield Therapeutics1282011-08-012020-10-30
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
ST10-021, Placebo Comparator - Iron Deficiency Anaemia, Inflammatory Bowel Disease
Phase 3CompletedShield Therapeutics1282011-08-012020-10-30

Conditions studied

Anemia, Iron-Deficiency (9)  ·  Anemia (4)  ·  Inflammatory Bowel Diseases (4)  ·  Iron Deficiencies (4)  ·  Crohn Disease (2)  ·  Colitis, Ulcerative (1)  ·  Deficiency Diseases (1)  ·  Intestinal Diseases (1)  ·  Renal Insufficiency, Chronic (1)

Interventions

ferric maltol (8)  ·  ferric trimaltol (4)  ·  Iron-Dextran Complex (1)  ·  ferrous sulfate (1)

Countries

United States (4)  ·  United Kingdom (3)  ·  Germany (2)  ·  Belgium (1)  ·  France (1)  ·  Hungary (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Nicholas Mallard, PhD (2)  ·  David Pittrow, MD, PhD (1)  ·  Jackie Mitchell, DPhil (1)  ·  Jackie Mitchell, PhD (1)  ·  Mark Sampson, MBChB (1)  ·  Stefan Schreiber, MD, PhD (1)

Results publications

PMID 25545376, PMID 27237709, PMID 34029682